Summary
Updated Aug 30, 2026
Cynthia M. Butitta is Director of Autolus Therapeutics plc (AUTL). 7 SEC Form 4 filings on record going back to 2025, most recently on 1 July 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Cynthia M. Butitta has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Cynthia M. Butitta files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark Schoenberg - $4.46M of URGN open-market activity in the last 12 months
- David C. Myles - $3.11M of OLMA open-market activity in the last 12 months
- Shane William Charles Kovacs - $2.98M of OLMA open-market activity in the last 12 months
- Shawnte Mitchell - $952K of OLMA open-market activity in the last 12 months
- Cyrus Harmon - $866K of OLMA open-market activity in the last 12 months
- Jason Drew Smith - $176K of URGN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Cynthia M. Butitta?
Cynthia M. Butitta is a corporate insider, tracked as Director of Autolus Therapeutics plc (AUTL). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Cynthia M. Butitta submitted recently?
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Where can I see all of Cynthia M. Butitta's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Cynthia M. Butitta and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
